Exploring the Discovery & Development of an Oral Trispecific Cancer Drug

Time: 11:45 am
day: Day One


  • Developing new understanding of existing targets and their functions
  • Acquiring awareness of novel targets and the potential for new inhibitor development
  • Combining multiple cancer fighting properties in one drug and advancing clinical biomarker utility in the epigenetic space